Clinical Trials

Break Free from Alcohol Use Disorder

Join a clinical research study evaluating Deep TMS® — a non-invasive treatment designed to help reduce heavy drinking and cravings.
No cost to participate. Compensation provided.

A New Option for Those Looking to Cut Back

Heavy alcohol use can take a toll on both your physical and mental health. Research shows that even reducing heavy drinking days for several months can lead to meaningful improvements in overall well-being.
BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS®) is being studied as a potential new tool to help people with Alcohol Use Disorder (AUD) reduce cravings and heavy drinking. This study will compare active Deep TMS® with a placebo-like (sham) treatment to evaluate its effectiveness. 

What to Expect

Study Participation in the Alcohol Use Disorder Clinical Trials Includes:
  • screening visit to confirm eligibility
  • 36 total visits over approximately 6 months
  • About 15 visits during the first 3–5 weeks
  • Then one visit per week for about 5 months
  • Each visit includes either Deep TMS® or sham TMS plus educational sessions about alcohol use, coping skills, and behavioral change strategies
  • No cost to participate, and eligible participants will receive compensation for their time

Who Can Join:

You may qualify if you:
  • Are 18–86 years old
  • Have had 24 or more heavy drinking days in the past 90 days (5+ drinks/day for men, 4+ for women)
  • Are seeking treatment to reduce or stop heavy drinking
  • Can provide informed consent and comply with study procedures

Who Can Not Join:

You may not qualify if you:
  • Have metal implants in the head or neck
  • Have received TMS treatment within the past year
  • Are pregnant, nursing, or planning pregnancy

Dr. Tendler has randomized device and pharmacological clinical trial experience with major depression, bipolar depression, PTSD, OCD, and smoking cessation. He has non-randomized research experience in Parkinson’s, schizophrenia, chronic pain, basic science microbiology, and tumor immunology.